Clinical Trial

New Approach in the Study of the Autonomic Nervous System Through Cardiac Variability in Sleep Apnea Syndrome.

Study acronym: HRVSAS
Recruiting
View on ClinicalTrials.gov →
Summary
The main objective of this study is to compare the different variations of the cardiac variability index measured thanks to the technique developed by the CIC-IT between subjects with severe SAS and healthy subjects with sleep pathology. In a first step, these two groups will be compared in REM sleep phase because it is the period during which the risk of sleep apnea syndrome is the highest. In a second step, the same methodology will be applied for the other sleep phases and correlations will be established with the other markers of cardiac variability (HRV) already known. This will allow to validate a reliable method of screening for SAS that is more accessible in ambulatory settings by means of a machine learning system based on artificial intelligence
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-29.
Status change: Not Yet Recruiting → Recruiting 2025-05-22
Trial Details
NCT Number NCT06808464
Lead Sponsor University Hospital, Lille
Conditions Sleep Apnea
Enrollment 97 participants
Start Date 2025-05-14
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2025-05-29